Search results
Vivani to start in-human trial for GLP-1 implant for treating obesity
Medical Device Network· 2 days agoGlobalData estimates that GLP-1 receptor agonist sales for T2D and obesity markets will reach more...
Myricx Bio gains $114m in Series A round to develop NMTi-ADCs
Pharmaceutical Technology· 6 days agoThe capital injection will be channelled into expanding Myricx’s NMTi inhibitor ADC payload...
US FTC to sue drug middlemen over insulin prices, source says - ET HealthWorld
The Economic Times· 4 days agoLondon: The U.S. Federal Trade Commission is planning to sue UnitedHealth, Cigna and CVS Health over...
A London biotech raises $114M to hone a new ADC payload
BioPharma Dive· 6 days agoInvestors Novo Holdings and Abingworth co-led its Series A, with participation from British Patient...
India set to witness obesity pill revolution? As patents near expiry, pharma giants gear up for...
Financial Express· 7 days agoBlockbuster obesity drugs like Ozempic and Wegovy have become a global sensation. Now the Indian...
Longeveron scores RMAT designation for Alzheimer’s cell therapy
Pharmaceutical Technology· 4 days agoThe global market for Alzheimer’s treatments is expected to be worth over $15.9bn in 2030, as per a...
Pfizer research chief Dolsten to step down, with company at a crossroads
BioPharma Dive· 5 days agoThe company has begun searching for a successor to Dolsten, who oversaw more than 35 drug and...
Amylyx to rebuild pipeline with $35m Phase III ready GLP-1RA acquisition
Clinical Trials Arena· 4 days agoNo trials have been conducted in either type 2 diabetes (T2D) or obesity where the field of GLP-1RAs...
Expresso Health News Updates of the week
Indian Express· 2 days agoLet us begin with our top story: Given Delhi’s air pollution, sulfur dioxide, nitrogen dioxide, and particulate matter can deposit on the scalp and hair leading to dandruff. At the same time ...
Impact of AI on metabolic disorder clinical trials
Clinical Trials Arena· 3 days agoMore clinical trials in metabolic research should be expected, especially since pharma giants have entered partnerships with AI companies. For example, ...